Transperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients

Brachytherapy

Volumn 8, Issue 2, 2009, Pages 210-217

  Prada, Pedro J ^a   Gonzalez, Herminio ^a   Menéndez, Consuelo ^a   Llaneza, Ana ^a   Fernández, José ^a   Santamarta, Elena ^a   Ricarte, Pedro Pérez ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Brachytherapy; Hyaluronic acid; Prostate cancer; Rectal protection and toxicity

Indexed keywords

HYALURONIC ACID; IODINE 125;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RISK; CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; RECTUM HEMORRHAGE;

ADIPOSE TISSUE; AGED; BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENDOSONOGRAPHY; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OUTPATIENTS; RADIODERMATITIS; RADIOTHERAPY, CONFORMAL; RECTUM; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VISCOSUPPLEMENTS;

EID: 67349279567     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2008.11.010     Document Type: Article

References (30)

1. D́Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969-974
2. Potters L., Klein E.A., Kattan M.W., et al. Monotherapy for stage T1-T2 prostate cancer: Radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 71 (2004) 1111-1133
3. Sharkey J., Cantor A., Solc Z., et al. 103Pb brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer: 12-Year experience from a single group practice. Brachytherapy 4 (2005) 33-34
4. Ash D., Flynn A., Battermann J., et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 57 (2000) 315-321
5. Merrick G.S., Butler W.M., Wallner K.E., et al. Variability of prostate brachytherapy preimplant dosimetry: A multi-institutional analysis. Brachytherapy 5 (2005) 241-251
6. Daphna Y., Gelblum L.P., and Potters L. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 48 (2000) 119-124
7. Merrick G.S., Butler W.M., Dorsey M.S., et al. Rectal dosimetric analysis following prostate brachytherapy. Int J Radiat Oncol Biol Phys 43 (1999) 1021-1027
8. Hu K., and Wallner K. Clinical course of rectal bleeding following I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 41 (1998) 263-265
9. Wallner K., Roy J., and Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 32 (1995) 465-471
10. Blasko J.C., Ragde H., and Grimm P.D. Transperineal ultrasound-guided implantation of the prostate: Morbidity and complications. Scand J Urol Nephrol Suppl 137 (1991) 113-118
11. Wallner K., Roy J., and Harrison L. Tumor control and morbidity following transperineal I-125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol 14 (1996) 449-453
12. Prada P.J., Fernandez J., Martinez A., et al. Transperineal injection of hyaluronic acid in the anterior peri-rectal fat to decease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients. Int J Oncol Biol Phys 69 (2007) 95-102
13. Bice Jr. W.S., Prestidge B.R., Prete J.J., et al. Clinical impact of implementing the recommendations of AAPM Task Group 43 on permanent prostate brachytherapy using 125I. American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys 40 (1998) 1237-1241
14. George E. Intra-articular hyaluronan treatment for osteoarthritis. Ann Rheum Dis 57 (1998) 637-640
15. Wobig M., Bach G., Beks P., et al. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: A comparison of Hyalan G-F20 and a lower molecular weight hyaluronan. Clin Ther 21 (1999) 1549-1562
16. Wachter S., Gerstner N., Goldner G., et al. Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma. Radiother Oncol 54 (2000) 11-19
17. Crespi M., Delvaux M., Schaprio M., et al. Working party report by the committee for minimal standards of terminology and documentation in digestive endoscopy of the European society of gastrointestinal endoscopy. Minimal standard terminology for a computerized endoscopic data base. Ad hoc task force of the committee. Am J Gastroenterol 91 (1996) 191-216
18. SPSS Inc. Headquarters. Chicago, IL. V15. 2008.
19. Prada P.J., De La Rua A., Hevia M., et al. High dose brachytherapy (real time) in patients with intermediate or high risk prostate cancer: Technical description and preliminary experience. Clin Transl Oncol 7 (2005) 389-397
20. Pollack A., and Zagars G.K. External beam radiotherapy dose-response of prostate cancer. Int J Radiat Oncol Biol Phys 15 (1988) 1299
21. Pollack A., Zagars G.K., Smith L.G., et al. Preliminary results of a randomized radiotherapy dose escalation study comparing 70 Gy to 78 Gy for prostate cancer. J Clin Oncol 18 (2000) 3904
22. Hanks G.E., Hanlon A.L., Pinover W.H., et al. Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiot Oncol Biol Phys 46 (2000) 823-832
23. Teshima T., Hanks G.E., Hanlon A.L., et al. Rectal bleeding after conformal 3D treatment of prostate cancer: Time to occurrence, response to treatment and duration of morbidity. Int J Radiat Oncol Biol Phys 39 (1997) 77-83
24. Donner C.S. Pathophysiology and therapy of chronic radiation-induced injury to the colon. Dig Dis 16 (1998) 253-261
25. Shah J.N., and Ennis R.D. Rectal toxicity profile after transperineal interstitial permanent prostate brachytherapy: Use of a comprehensive toxicity scoring system and identification of rectal dosimetric toxicity predictors. Int J Radiat Oncol Biol Phys 64 (2006) 817-824
26. Snyder K.M., Stock R.G., Hong S.M., et al. Defining the risk of developing grade 2 proctitis following iodine 125 prostate brachytherapy using a rectal dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 50 (2001) 335-341
27. Waterman F.M., and Dicker A.P. Probability of late rectal morbidity in iodine 125 prostate brachytherapy. Int J Radait Oncol Biol Phys 55 (2003) 342-353
28. Battermann J.J., Boon T.A., and Moerland A. Results of permanent prostate brachytherapy, 13 years of experience at a single institution. Radiother Oncol 71 (2004) 23-28
29. Blasko J.C., Wallner K., Grimm P.D., et al. Prostate specific antigen based disease control following ultrasound guided iodine-125 implantation for state Tl/T2 prostatic carcinoma. J Urol 154 (1995) 1096-1099
30. Sylvester J.E., Blasko J.C., Grimm P.D., et al. Ten-year biochemical control relapse-free survival after external beam irradiation and brachytherapy for localized prostatic cancer: The Seattle experience. Int J Radiat Oncol Biol Phys 57 (2003) 952-964